Overview
Current Appointments & Affiliations
Professor of Ophthalmology
·
2013 - Present
Ophthalmology, Glaucoma,
Ophthalmology
Chief, Glaucoma Ophthalmology
·
2015 - Present
Ophthalmology, Glaucoma,
Ophthalmology
Recent Publications
Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study.
Journal Article Am J Ophthalmol · July 2025 PURPOSE: To evaluate the safety and intraocular pressure (IOP)-lowering efficacy of the ocular pressure adjusting pump in subjects with normal-tension glaucoma (NTG). DESIGN: Prospective, multicenter, masked, randomized, fellow-eye controlled trial. SUBJEC ... Full text Link to item CiteOutcome of Glaucoma Drainage Device Surgeries in Nigeria.
Journal Article Niger J Clin Pract · July 1, 2025 BACKGROUND: Glaucoma is the leading cause of functional low vision and irreversible blindness in Nigeria and constitutes a significant public health burden. Glaucoma Drainage Devices(GDD) an increasingly popular option for glaucoma treatment and are relati ... Full text Link to item CiteGlaucoma Surgery SOS: Emergency Department Utilization Greater among Younger and First-Time Surgical Patients with Glaucoma.
Journal Article Ophthalmol Glaucoma · 2025 PURPOSE: To describe the frequency, findings, and interventions of patients' emergency department (ED) visits after all types of glaucoma surgery DESIGN: Retrospective cohort study SUBJECTS: All surgical patients with glaucoma between 2013 and 2021 METHODS ... Full text Link to item CiteRecent Grants
A Prospective, Multicenter, Non-Randomized, Clinical Trial Designed to Evaluate the Safety and Feasibility of the ELIOS System to Reduce Intraocular Pressure in Patients with Primary Open-Angle Glaucoma as a Standalone Procedure
Clinical TrialPrincipal Investigator · Awarded by Elios Vision, Inc. · 2025 - 2030A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTXTIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT)
Clinical TrialPrincipal Investigator · Awarded by Ocular Therapeutix Inc · 2022 - 2024Evaluating the use of a sustained-release intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) in Minimally invasive glaucoma surgery (MIGS)
ResearchPrincipal Investigator · Awarded by Ocular Therapeutix Inc · 2021 - 2024View All Grants
Education, Training & Certifications
University of North Carolina, Chapel Hill ·
1991
M.D.